Prostaglandins, Leukotrienes and Essential Fatty Acids
Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial
Introduction
There is increasing evidence from epidemiological and clinical studies that n-3 PUFA exert a beneficial effect on several risk factors of coronary heart disease (CHD) and, accordingly, might be important for primary and secondary prevention [1], [2], [3], [4]. A reduced incidence of fatal myocardial infarction by nearly 50% in populations on a habitual diet rich in fatty fish as well as a decreased rate of lethal reinfarction by 30% despite unchanged plasma cholesterol levels after fish diet or fish-oil supplementation [5], [6] were assumed to be due to diminished coronary thrombosis and lethal cardiac arrhythmias. Moreover, recent epidemiological results indicate a reduced incidence of sudden cardiac death by a diet rich in n-3 PUFA [7], [8], [9]. Sudden death is often found in patients with CHD but will even occur if signs of CHD are absent. It might be predicted by recording cardiac arrhythmias even in patients with asymptomatic or mildly symptomatic ventricular premature complexes (VPC).
In numerous animal experiments an antiarrhythmic action of n-3 PUFA was found [10], [11], [12], [13]. However, only few clinical data are available which suggest an evidence-based recommendation of n-3 PUFA to reduce ventricular arrhythmias in clinical practice [14], [15], [16], [17]. We, therefore, designed a study to examine the antiarrhythmic effect of encapsulated fish oil on cardiac arrhythmias in patients without signs of CHD and heart failure.
Section snippets
Patients
A total of 65 patients (32 male, 33 female) with cardiac arrhythmias without signs of CHD and heart failure were randomly allocated to 2 subgroups. The first group (n=33) was supplemented with 3 g/day of fish oil (3×2 or 2×3 capsules a 0.5 g) over 6 months. The other group (n=32) was given 3 g/day of olive oil (3×2 capsules or 2×3 capsules a 0.5 g) as placebo.
The mean age of the fish oil group (17 male, 16 female) was 45±8 years (mean±SD), the body height being 167±10 cm and body weight 74±10 kg. The
Results
Selected n-6 and n-3 PUFA of serum triglycerides being estimated to verify the patients’ compliance are shown in Table 1. In the fish oil group EPA and DHA were significantly increased whereas linoleic acid (LA) was decreased at the end of the dietary period. The values returned to the initial level 6 months after finishing the fish-oil supplementation (control). In the placebo group except a slight increase of oleic acid the values remained unchanged (not demonstrated).
Biochemical data and
Discussion
Numerous epidemiological, clinical and experimental data indicate a beneficial effect of dietary n-3 PUFA on the risk of CHD and sudden cardiac death [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17]. The reduced incidence of fatal reinfarction [5], [6] despite unchanged plasma cholesterol levels and of sudden cardiac death [7], [8], [9], [10] suggest diminished ventricular arrhythmias in populations ingesting a habitual diet rich in fatty fish or
References (36)
- et al.
Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action
J. Nutr.
(1997) - et al.
n-3 Fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias
Nutr. Res.
(1995) - et al.
Effects of dietary fish oil on ventricular premature complexes
Am. J. Cardiol.
(1995) - et al.
Fish consumption, n-3 fatty acids in cell membranes and heart rate variability in survivers of myocardial infarction with left ventricular dysfunction
Am. J. Cardiol.
(1997) - et al.
Blood pressure and serum lipids from SHR after diets supplemented with evening primrose, sunflowerseed or fish oils
Prostaglandins Leukot. Essent. Fatty Acids
(1990) - et al.
Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension
Atherosclerosis
(1986) Fish oil and plasma lipid and lipoprotein metabolism in humansa critical review
J. Lipid Res.
(1989)- et al.
A possible contribution of decrease in free fatty acids to low serum triglyceride levels after diets supplemented with n-6 and n-3 polyunsaturated fatty acids
Atherosclerosis
(1990) - et al.
Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischemic myocardium
J. Mol. Cell. Cardiol.
(1982) - et al.
The inverse relation between fish consumption and 20-year-mortality from coronary heart disease
N. Engl. J. Med.
(1985)
Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
World Rev. Nutr. Diet.
Fish consumption and 30-year risk of fatal myocardial infarction
N. Engl. J. Med.
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women
J. Am. Med. Assoc.
Effects of changes in fat, fish and fibre intake on death and myocardial reinfarction trial (DART)
Lancet
Fish consumption and risk of sudden cardiac death
J. Am. Med. Assoc.
Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
Am. J. Clin. Nutr.
Blood levels of long-chain n-3 fatty acids and the risk of sudden death
N. Engl. J. Med.
Cited by (49)
Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids
2018, Prostaglandins and Other Lipid MediatorsCitation Excerpt :The strongest evidence for a beneficial effect of ω-3 fats is mostly related to the heart [78]. Supplementation with ω-3 PUFAs has been reported to have several beneficial effects including reducing cardiovascular mortality [79,80], improved lipid profile [81,82], anti-inflammatory effects [83], reducing cardiac arrhythmias [82], vasodilatory mechanisms [84] and anti-platelet effects [85]. However, pinpointing the cardioprotective therapeutic effects of ω-3 PUFAs remains challenging, as large clinical trials predominantly demonstrated neutral effects of ω-3 PUFAs in placebo-controlled studies.
Fish consumption, low-level mercury, lipids, and inflammatory markers in children
2012, Environmental ResearchCitation Excerpt :There is considerable evidence that consuming fish is associated with a reduced risk of cardiovascular disease (CVD; Mozaffarian and Rimm, 2006). This is likely derived from fish being a source of long chain omega-3 polyunsaturated fatty acids, which have been shown to decrease CVD risk (Dolecek and Grandits, 1991) and promote an atheroprotective lipid profile (Singer and Wirth, 2004). These benefits to cardiovascular health have led to calls for greater fish consumption (Kris-Etherton et al., 2003; Food and Agriculture Organization of the United Nations, World Health Organization, 2010).
Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis
2009, International Journal of CardiologyCitation Excerpt :Using our pre-specified search methodology we retrieved 670 abstracts, of which 248 were considered potentially suitable (Fig. 1). After full text review, 47 were included in the final analysis (Table 1) [27–70]. Studies were eliminated if they did not meet the a priori inclusion criteria.
Diet and Sudden Death: How to Reduce the Risk
2022, Current Vascular PharmacologyObesity, nutrition and heart rate variability
2021, International Journal of Molecular Sciences